KNC Laboratories, The Current Fiscal Year Ordinary Profit Revised Downward by 35%

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Fri Feb 14, 2025 3:30 pm JST Earnings

6568 KNC Laboratories Co., Ltd. 【J-GAAP】

Earnings Report

KNC Laboratories Co., Ltd. <6568> [TSE Growth] announced its financial results after the market closed on February 14th (15:30). The ordinary profit (non-consolidated) for the cumulative third quarter of the fiscal year ending March 2025 (April to December) dropped 44.0% from the same period last year to 0.48 billion yen.

In addition, the full-year ordinary profit has decreased 34.8%, from the previous forecast of 1.38 billion yen to 0.9 billion yen (compared to 2.09 billion yen in the previous period), leading to an increase in the profit decline rate from 34.1% to 57.0%.

Based on the full-year plan announced by the company after the downward revision, our estimate of the ordinary profit for the October to March period (2H) has decreased 37.1%, from the previous forecast of 1.29 billion yen to 0.81 billion yen (compared to 1.45 billion yen in the same period of the previous year), leading to an increase in the profit decline rate from 11.3% to 44.2%.

In the most recent three-month period, from October to December (3Q), the ordinary profit increased 73.8% from the same period last year, reaching 0.39 billion yen. The operating profit margin rose from 12.3% in the same period last year to 12.7%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Dec, 2022	4,763	880	911	628	81.5	41.4	Feb 10, 2023	J-GAAP
Apr - Dec, 2023	5,184	850	864	595	77.2	41.3	Feb 9, 2024	J-GAAP
Apr - Dec, 2024	5,254	322	484	338	43.9	53.8	Feb 14, 2025	J-GAAP
YoY	+1.4%	-62.1%	-44.0%	-43.2%	-43.2%

Guidance Update

Second Half Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2024 Prev	5,678	1,304	1,294	906	117.2	17	Nov 8, 2024	J-GAAP
Oct - Mar, 2024 New	4,528	674	814	585	75.7	17	Feb 14, 2025	J-GAAP
Revision Rate	-20.3%	-48.3%	-37.1%	-35.4%	-35.4%

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2025 Prev	9,000	1,380	1,380	960	124.2	33	May 13, 2024	J-GAAP
Mar, 2025 New	7,850	750	900	639	82.7	33	Feb 14, 2025	J-GAAP
Revision Rate	-12.8%	-45.7%	-34.8%	-33.4%	-33.4%

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	5,782	1,453	1,459	1,053	136.5	15	May 13, 2024	J-GAAP
Oct - Mar, 2024 Guidance	4,528	674	814	585	75.7	17	Feb 14, 2025	J-GAAP
YoY	-21.7%	-53.6%	-44.2%	-44.4%	-44.6%

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	8,628	2,163	2,199	1,542	200.1	28	May 12, 2023	J-GAAP
Mar, 2024	9,154	2,081	2,094	1,493	193.5	30	May 13, 2024	J-GAAP
Mar, 2025 Guidance	7,850	750	900	639	82.7	33	Feb 14, 2025	J-GAAP
YoY	-14.2%	-64.0%	-57.0%	-57.2%	-57.3%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	1,812	222	229	155	20.1	12.3	Feb 9, 2024	J-GAAP
Jan - Mar, 2024	3,970	1,231	1,230	898	116.4	31.0	May 13, 2024	J-GAAP
Apr - Jun, 2024	1,405	85	87	56	7.3	6.0	Aug 9, 2024	J-GAAP
Jul - Sep, 2024	1,917	-9	-1	-2	-0.3	-0.5	Nov 8, 2024	J-GAAP
Oct - Dec, 2024	1,932	246	398	284	36.8	12.7	Feb 14, 2025	J-GAAP
YoY	+6.6%	+10.8%	+73.8%	+83.2%	+83.2%